Head-To-Head Review: Utah Medical Products (NASDAQ:UTMD) and Axonics Modulation Technologies (NASDAQ:AXNX) – Slater Sentinel

Axonics Modulation Technologies (NASDAQ:AXNX) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, profitability and earnings.

Earnings and Valuation

This table compares Axonics Modulation Technologies and Utah Medical Products revenue, earnings per share and valuation.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Axonics Modulation Technologies and Utah Medical Products, as provided by MarketBeat.com.

Axonics Modulation Technologies presently has a consensus price target of $43.13, suggesting a potential upside of 40.15%. Given Axonics Modulation Technologies higher possible upside, equities research analysts clearly believe Axonics Modulation Technologies is more favorable than Utah Medical Products.

Volatility and Risk

Axonics Modulation Technologies has a beta of -1.69, meaning that its share price is 269% less volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

Profitability

This table compares Axonics Modulation Technologies and Utah Medical Products net margins, return on equity and return on assets.

Institutional & Insider Ownership

37.3% of Axonics Modulation Technologies shares are held by institutional investors. Comparatively, 76.4% of Utah Medical Products shares are held by institutional investors. 36.0% of Axonics Modulation Technologies shares are held by insiders. Comparatively, 7.3% of Utah Medical Products shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Utah Medical Products beats Axonics Modulation Technologies on 8 of the 12 factors compared between the two stocks.

Axonics Modulation Technologies Company Profile

Axonics Modulation Technologies, Inc., a medical technology company, focuses on the design, development, and commercialization of sacral neuromodulation solutions (SNM) solutions. The SNM therapy is primarily used to treat patients with overactive bladder, including urinary urgency incontinence and urinary urgency frequency, fecal incontinence, and urinary retention. Its proprietary r-SNM System delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of urinary and fecal dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was founded in 2012 and is based in Irvine, California.

Utah Medical Products Company Profile

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; MYELO-NATE, a lumbar sampling kit; and HEMO-NATE, a disposable filter. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It markets its products to neonatal intensive care unit, labor and delivery department, women's health center in hospitals, outpatient clinics, and physician's offices. The company sells its products through customer service and sales force, independent consultants, and independent manufacturer representatives. Utah Medical Products, Inc. was founded in 1978 and is headquartered in Midvale, Utah.

Receive News & Ratings for Axonics Modulation Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axonics Modulation Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Continue reading here:
Head-To-Head Review: Utah Medical Products (NASDAQ:UTMD) and Axonics Modulation Technologies (NASDAQ:AXNX) - Slater Sentinel